The Locking Cap Joins CLAAD for Drug Abuse Prevention Policy Meeting in Washington, DC

The Locking Cap Joins CLAAD for Drug Abuse Prevention Policy Meeting in Washington, DC

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

(PRWEB) November 22, 2013

The Locking Cap, the manufacturer of a combination bottle cap for prescription drugs, was in attendance at the CLAAD Prescription Drug Abuse National Policy Consensus Meeting on November 19 in Washington, DC. The meeting is a gathering of stakeholders from across the nation to work together and prevent drug abuse, with sponsors donating to CLAAD, the Center for Lawful Access and Abuse Deterrence to prevent drug abuse. The Locking Cap is among the commercial members of CLAAD.

The Locking Cap pill safe product was recently highlighted on the Tucson AZ news program, Tucson News Now, for their development of the innovative combination prescription bottle cap. The news show revealed that the locking medication bottle, a combination lock bottle cap, had been named a top five technology for preventing prescription drug abuse at last years Prescription Drug Abuse National Policy Consensus Meeting. The Locking Cap is designed to deter abuse. It forces thieves to destroy the bottle before they can access the contents.

A New Pill Safe, The Locking Cap
The locking medication bottle secures prescription drugs at home and discourages children and teenagers from gaining access. If the drugs are stolen or the bottle destroyed, the prescription holder is alerted to the abusive behavior. Stealing prescription drugs is a major contributor to drug abuse in kids.

CLAAD
The not-for-profit CLAAD coordinates the national effort to prevent prescription drug fraud, diversion, misuse and abuse while supporting patient access to high quality health care. According to their website, “CLAAD brings together health professionals, law enforcement, business, government and others to work together and improve public health and safety.”

Concensus Meeting
The National Prescription Drug Abuse Prevention Policy Consensus Meeting is an assembly of business and academic groups who share a clear vision of the problem and wish to find a unanimity going forward in the effort to diminish prescription drug abuse. Members or organizations who are affected by prescription drug abuse will attend, and while they want to prevent drug abuse, they are equally concerned with the effectiveness and efficiency of health care. Prescription drugs are important in the treatment of disease, illness and injury.

The consensus meeting addresses an agenda this year with the following topics:
Abuse Deterrent Medications
Access to Treatment, including access to medication treatment
Data collection and analysis
Law enforcement and prosecutions
Prescribe education
Prescription monitoring programs
Testing for substance abuse disorders
Safe storage and responsible disposal

For more information on the consensus meeting, visit http://claad.org/consensus-meeting/. For more information on Locking Caps, visit their website at http://www.thelockingcap.com or call Nathan Langley, Co-Founder & VP of Sales at 916-412-0822.


Contact